HUP0200733A2 - GABA analógokat és triciklusos vegyületeket tartalmazó kombinációk depresszíó kezelésére - Google Patents

GABA analógokat és triciklusos vegyületeket tartalmazó kombinációk depresszíó kezelésére

Info

Publication number
HUP0200733A2
HUP0200733A2 HU0200733A HUP0200733A HUP0200733A2 HU P0200733 A2 HUP0200733 A2 HU P0200733A2 HU 0200733 A HU0200733 A HU 0200733A HU P0200733 A HUP0200733 A HU P0200733A HU P0200733 A2 HUP0200733 A2 HU P0200733A2
Authority
HU
Hungary
Prior art keywords
combinations
tricyclic compounds
treat depression
gaba analogs
gaba
Prior art date
Application number
HU0200733A
Other languages
English (en)
Inventor
Leslie Magnus
Douglas A. Saltel
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of HUP0200733A2 publication Critical patent/HUP0200733A2/hu
Publication of HUP0200733A3 publication Critical patent/HUP0200733A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0200733A 1999-04-09 2000-02-16 Combinations of gaba analogs and tricyclic compounds to treat depression HUP0200733A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12857199P 1999-04-09 1999-04-09

Publications (2)

Publication Number Publication Date
HUP0200733A2 true HUP0200733A2 (hu) 2002-07-29
HUP0200733A3 HUP0200733A3 (en) 2003-04-28

Family

ID=22435960

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200733A HUP0200733A3 (en) 1999-04-09 2000-02-16 Combinations of gaba analogs and tricyclic compounds to treat depression

Country Status (11)

Country Link
EP (1) EP1180058A1 (hu)
JP (1) JP2002541224A (hu)
KR (1) KR20010108466A (hu)
AU (1) AU3492900A (hu)
CA (1) CA2367494A1 (hu)
HU (1) HUP0200733A3 (hu)
IL (1) IL145736A0 (hu)
NZ (1) NZ514401A (hu)
TR (1) TR200102850T2 (hu)
WO (1) WO2000061234A1 (hu)
ZA (1) ZA200108259B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003167A1 (en) 1996-07-24 1998-01-29 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
CA2473536A1 (en) * 2002-01-16 2003-07-31 Endo Pharmaceuticals, Inc. Pharmaceutical composition and method for treating disorders of the central nervous system
RU2006107534A (ru) * 2003-09-12 2007-09-20 Уорнер-Ламберт Компани Ллс (Us) Комбинация, включающая альфа-2-дельта-лиганд анд и ssri и/или snri, для лечения депрессии и тревожного расстройства
RU2320369C2 (ru) * 2003-09-12 2008-03-27 Пфайзер Инк. Комбинации, содержащие альфа-2-дельта лиганды и ингибиторы обратного захвата серотонина/норадреналина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2410821A1 (de) * 1974-03-07 1975-09-18 Hoechst Ag Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung
FR2453643A2 (fr) * 1977-06-24 1980-11-07 Synthelabo Compositions pharmaceutiques actives sur le systeme nerveux central
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
AU9137091A (en) * 1990-11-27 1992-06-25 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
EP0726073A3 (en) * 1995-02-10 1998-07-08 Eduardo Samuel Bleiweiss Pharmaceutical compositions containing at least one of haloperidol, imipramine or trifluoroperazine

Also Published As

Publication number Publication date
TR200102850T2 (tr) 2002-03-21
IL145736A0 (en) 2002-07-25
HUP0200733A3 (en) 2003-04-28
AU3492900A (en) 2000-11-14
JP2002541224A (ja) 2002-12-03
WO2000061234A1 (en) 2000-10-19
NZ514401A (en) 2003-10-31
KR20010108466A (ko) 2001-12-07
CA2367494A1 (en) 2000-10-19
ZA200108259B (en) 2003-03-26
EP1180058A1 (en) 2002-02-20

Similar Documents

Publication Publication Date Title
EP1005330A4 (en) METHODS AND COMPOSITIONS FOR TARGETING COMPOUNDS TO MUSCLES
HUP9900065A3 (en) Use of cgmp-phosphodiesterase inhibitors to treat impotence
IL158420A0 (en) Use of follistatin to increase muscle mass
GB9705349D0 (en) Treatment of effluent streams
IL147748A0 (en) Use of etodolac to treat cancer
IL144926A0 (en) Distribution of calls to inquiry centers
EP1235785A4 (en) NEW CONNECTIONS FOR THE TREATMENT OF DIABETES AND ASSOCIATED DISEASES
IL145736A0 (en) Combinations of gaba analogs and tricyclic compounds to treat depression
IL146237A0 (en) Autotaxin variants and uses to treat diseases of metabolism
GB2353217B (en) Use of ribose to treat fibromyalgia
GB9923951D0 (en) Treatment of gas mixture
HUP0002896A3 (en) Use of polyelectrolytes as sequestering agents
GB9921341D0 (en) Initiation of oestrus
TW469837U (en) Improved structure of magnetically-controlled flywheel for exercise bicycle
TW431182U (en) Improved structure of massaging wheel
TW481990U (en) Structure of massage pedal
HUP0103568A3 (en) Treatment of depression
TW410639U (en) Improved structure of exercise wheel
TW408753U (en) Improved pedal fastening structure of bicycle
AU6191201A (en) Treatment of effluent
TW441356U (en) Structure of saddle-type massage pad
TW428489U (en) Structure of chess set
TW462310U (en) Improved structure of turning wheel for game device
TW410644U (en) Improved structure of exercise wheel
TW568132U (en) Improved structure of spatula